Clinical implications of antibiotic pharmacokinetic-pharmacodynamic parameters

被引:3
|
作者
Cohen, R. [1 ,2 ]
机构
[1] Hop Intercommunal Creteil, Microbiol Serv, F-94010 Creteil, France
[2] Assoc Clin & Therapeut Infantile Val Marne ACTIV, F-94010 Creteil, France
来源
ARCHIVES DE PEDIATRIE | 2008年 / 15卷
关键词
D O I
10.1016/S0929-693X(08)74216-7
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The progress in the knowledge of antibiotic action mechanism have led to determine phamacodynamic/pharmacokinetic (PK/PD) parameters predictive of antibiotic efficacy in bacterial infections. These parameters could vary according to the antibiotic compound, the bacterial specie implicated, the localization of the infection, the severity of the disease. The serum PK/PD parameters are predictive of efficacy in several infections (respiratory, skin, bone) and become a major criterion for selecting antibiotics in clinical practice. Moreover, these PK/PD parameters are the cornerstone of pre-clinical development of antibiotics, the determination of dosage and for the establishment of breakpoints for classifying strains in the sensitive or resistant area, (C) 2008 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:S53 / S58
页数:6
相关论文
共 50 条
  • [21] Pharmacokinetic-pharmacodynamic modeling of opioids
    Lötsch, JR
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2005, 29 (05) : S90 - S103
  • [22] Pharmacokinetic-pharmacodynamic relationships for benzodiazepines
    Laurijssens, BE
    Greenblatt, DJ
    CLINICAL PHARMACOKINETICS, 1996, 30 (01) : 52 - 76
  • [23] Pharmacokinetic-pharmacodynamic correlations in psychopharmacology
    Danhof, M.
    BEHAVIOURAL PHARMACOLOGY, 2007, 18 : S112 - S113
  • [24] Microdialysis for pharmacokinetic-pharmacodynamic studies
    Yu, W.
    Cheng, Q.
    Feng, J.
    Li, F.
    PHARMAZIE, 2007, 62 (12): : 883 - 891
  • [25] PHARMACOKINETIC-PHARMACODYNAMIC MODELING IN PAIN
    Loetsch, J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 14 - 14
  • [26] Pharmacokinetic-pharmacodynamic modelling in anaesthesia
    Gambus, Pedro L.
    Troconiz, Inaki F.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 79 (01) : 72 - 84
  • [27] Evaluation of the pharmacokinetic-pharmacodynamic relationship of praziquantel in the schistosoma mansoni mouse model: possible clinical implications
    Abla, N.
    Keiser, J.
    Vargas, M.
    Reimers, N.
    Haas, H.
    Spangenberg, T.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2017, 22 : 136 - 137
  • [28] Current clinical use of reteplase for thrombolysis - A pharmacokinetic-pharmacodynamic perspective
    Martin, U
    Kaufmann, B
    Neugebauer, G
    CLINICAL PHARMACOKINETICS, 1999, 36 (04) : 265 - 276
  • [29] Current Clinical Use of Reteplase for ThrombolysisA Pharmacokinetic-Pharmacodynamic Perspective
    Ulrich Martin
    Burchard Kaufmann
    Günter Neugebauer
    Clinical Pharmacokinetics, 1999, 36 : 265 - 276
  • [30] GENESIS OF CLINICAL PHARMACOKINETIC-PHARMACODYNAMIC CONCEPTS - MARSHALL,EK ROLE
    LEVY, G
    ANNALS OF PHARMACOTHERAPY, 1994, 28 (11) : 1300 - 1302